| Application number | Title of the application | Filing Date | Status |
|---|
| 09/501364 | NEW ORAL FORMULATION | Feb 9, 2000 | Abandoned |
| 09/485251 | USE OF QUINAPRIL FOR TREATING MYOCARDIAL ISCHEMIA AND ANGINA | Feb 6, 2000 | Abandoned |
Array
(
[id] => 4409520
[patent_doc_number] => 06265381
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Orally-active elastase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/491814
[patent_app_country] => US
[patent_app_date] => 2000-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21198
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 322
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265381.pdf
[firstpage_image] =>[orig_patent_app_number] => 491814
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/491814 | Orally-active elastase inhibitors | Jan 27, 2000 | Issued |
Array
(
[id] => 7118329
[patent_doc_number] => 20010001658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-05-24
[patent_title] => 'Granule modulating hydrogel system'
[patent_app_type] => new-utility
[patent_app_number] => 09/490013
[patent_app_country] => US
[patent_app_date] => 2000-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2192
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20010001658.pdf
[firstpage_image] =>[orig_patent_app_number] => 09490013
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490013 | Granule modulating hydrogel system | Jan 20, 2000 | Abandoned |
Array
(
[id] => 4349683
[patent_doc_number] => 06214798
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'GnRH antagonists being modified in positions 5 and 6'
[patent_app_type] => 1
[patent_app_number] => 9/402698
[patent_app_country] => US
[patent_app_date] => 2000-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14157
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214798.pdf
[firstpage_image] =>[orig_patent_app_number] => 402698
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/402698 | GnRH antagonists being modified in positions 5 and 6 | Jan 2, 2000 | Issued |
Array
(
[id] => 7605268
[patent_doc_number] => 07115661
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-03
[patent_title] => 'Methods and compositions for mitigating pain'
[patent_app_type] => utility
[patent_app_number] => 09/473713
[patent_app_country] => US
[patent_app_date] => 1999-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21572
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115661.pdf
[firstpage_image] =>[orig_patent_app_number] => 09473713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/473713 | Methods and compositions for mitigating pain | Dec 28, 1999 | Issued |
| 09/462125 | BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS- AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES | Dec 26, 1999 | Abandoned |
Array
(
[id] => 4296491
[patent_doc_number] => 06197827
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Nicotine addiction treatment'
[patent_app_type] => 1
[patent_app_number] => 9/423897
[patent_app_country] => US
[patent_app_date] => 1999-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6523
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197827.pdf
[firstpage_image] =>[orig_patent_app_number] => 423897
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423897 | Nicotine addiction treatment | Nov 15, 1999 | Issued |
Array
(
[id] => 4371077
[patent_doc_number] => 06288074
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Method of treating lymphoproliferative syndrome'
[patent_app_type] => 1
[patent_app_number] => 9/439987
[patent_app_country] => US
[patent_app_date] => 1999-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2843
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288074.pdf
[firstpage_image] =>[orig_patent_app_number] => 439987
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/439987 | Method of treating lymphoproliferative syndrome | Nov 14, 1999 | Issued |
Array
(
[id] => 1494483
[patent_doc_number] => 06342481
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Oligopeptides derived from C-reactive protein fragments'
[patent_app_type] => B1
[patent_app_number] => 09/439164
[patent_app_country] => US
[patent_app_date] => 1999-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8254
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342481.pdf
[firstpage_image] =>[orig_patent_app_number] => 09439164
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/439164 | Oligopeptides derived from C-reactive protein fragments | Nov 11, 1999 | Issued |
Array
(
[id] => 4306895
[patent_doc_number] => 06326470
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Enhancement of accessibility of cellulose by expansins'
[patent_app_type] => 1
[patent_app_number] => 9/429675
[patent_app_country] => US
[patent_app_date] => 1999-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 41
[patent_no_of_words] => 17955
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326470.pdf
[firstpage_image] =>[orig_patent_app_number] => 429675
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/429675 | Enhancement of accessibility of cellulose by expansins | Oct 27, 1999 | Issued |
Array
(
[id] => 1462889
[patent_doc_number] => 06350759
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-26
[patent_title] => 'Dihydro- and tetrahydro-quinoline compounds'
[patent_app_type] => B1
[patent_app_number] => 09/425267
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9829
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 642
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/350/06350759.pdf
[firstpage_image] =>[orig_patent_app_number] => 09425267
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/425267 | Dihydro- and tetrahydro-quinoline compounds | Oct 21, 1999 | Issued |
Array
(
[id] => 1316399
[patent_doc_number] => 06608073
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-19
[patent_title] => 'Intranasal codeine for the rapid suppression of cough and rapid relief of pain'
[patent_app_type] => B1
[patent_app_number] => 09/410033
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3424
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/608/06608073.pdf
[firstpage_image] =>[orig_patent_app_number] => 09410033
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/410033 | Intranasal codeine for the rapid suppression of cough and rapid relief of pain | Sep 30, 1999 | Issued |
Array
(
[id] => 4178046
[patent_doc_number] => 06149948
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Method of decreasing plasma cholesterol and triglycerides with a chromium-containing complex'
[patent_app_type] => 1
[patent_app_number] => 9/406775
[patent_app_country] => US
[patent_app_date] => 1999-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 10030
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/149/06149948.pdf
[firstpage_image] =>[orig_patent_app_number] => 406775
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406775 | Method of decreasing plasma cholesterol and triglycerides with a chromium-containing complex | Sep 27, 1999 | Issued |
Array
(
[id] => 4247845
[patent_doc_number] => 06136785
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Protection from loss of sensory hair cells in the inner ear by administration of insulin-like growth factor and platelet derived growth factor'
[patent_app_type] => 1
[patent_app_number] => 9/376370
[patent_app_country] => US
[patent_app_date] => 1999-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 9341
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136785.pdf
[firstpage_image] =>[orig_patent_app_number] => 376370
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/376370 | Protection from loss of sensory hair cells in the inner ear by administration of insulin-like growth factor and platelet derived growth factor | Aug 17, 1999 | Issued |
Array
(
[id] => 7964121
[patent_doc_number] => 06680367
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-20
[patent_title] => 'Fluorescent CRF receptor-binding peptides'
[patent_app_type] => B1
[patent_app_number] => 09/356139
[patent_app_country] => US
[patent_app_date] => 1999-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7029
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680367.pdf
[firstpage_image] =>[orig_patent_app_number] => 09356139
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/356139 | Fluorescent CRF receptor-binding peptides | Jul 18, 1999 | Issued |
Array
(
[id] => 4328827
[patent_doc_number] => 06319914
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Cytoprotective effect of polycyclic phenolic compounds'
[patent_app_type] => 1
[patent_app_number] => 9/351492
[patent_app_country] => US
[patent_app_date] => 1999-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 6905
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319914.pdf
[firstpage_image] =>[orig_patent_app_number] => 351492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/351492 | Cytoprotective effect of polycyclic phenolic compounds | Jul 11, 1999 | Issued |
Array
(
[id] => 4089018
[patent_doc_number] => 06133235
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Glucagon-like insulinotropic peptides compositions and methods'
[patent_app_type] => 1
[patent_app_number] => 9/348136
[patent_app_country] => US
[patent_app_date] => 1999-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6794
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133235.pdf
[firstpage_image] =>[orig_patent_app_number] => 348136
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/348136 | Glucagon-like insulinotropic peptides compositions and methods | Jul 5, 1999 | Issued |
| 09/331197 | DRUGS FOR AMELIORATING OPHTHALMIC CIRCULATORY DISTURBANCE | Jun 24, 1999 | Abandoned |
Array
(
[id] => 1034562
[patent_doc_number] => 06875773
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-05
[patent_title] => 'Combination therapy for treatment of FIV infection'
[patent_app_type] => utility
[patent_app_number] => 09/763037
[patent_app_country] => US
[patent_app_date] => 1999-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6162
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875773.pdf
[firstpage_image] =>[orig_patent_app_number] => 09763037
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763037 | Combination therapy for treatment of FIV infection | May 27, 1999 | Issued |